Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - olanzapine, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; hypromellose; lactose monohydrate; carnauba wax; crospovidone; magnesium stearate; propylene glycol; ethanol; indigo carmine; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; colour - zyprexa is indicated for the treatment of schizophrenia and related psychoses. zyprexa alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. zyprexa is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - olanzapine, quantity: 7.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; carnauba wax; hyprolose; microcrystalline cellulose; crospovidone; lactose monohydrate; hypromellose; propylene glycol; indigo carmine; butan-1-ol; ethanol; isopropyl alcohol; shellac; strong ammonia solution; colour - zyprexa is indicated for the treatment of schizophrenia and related psychoses. zyprexa alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. zyprexa is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - olanzapine, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; carnauba wax; microcrystalline cellulose; crospovidone; hypromellose; hyprolose; colour; propylene glycol; indigo carmine; butan-1-ol; ethanol; isopropyl alcohol; shellac; strong ammonia solution - zyprexa is indicated for the treatment of schizophrenia and related psychoses. zyprexa alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. zyprexa is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - olanzapine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: carnauba wax; crospovidone; lactose monohydrate; microcrystalline cellulose; hypromellose; magnesium stearate; hyprolose; propylene glycol; indigo carmine; butan-1-ol; ethanol; isopropyl alcohol; shellac; strong ammonia solution; colour - zyprexa is indicated for the treatment of schizophrenia and related psychoses. zyprexa alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. zyprexa is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - fluoxetine hydrochloride -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; metacresol; hydrochloric acid; glycerol - other conditions: refrigerate - do not freeze. indications: for the treatment of insulin dependent diabetic patients.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: water for injections; sodium hydroxide; protamine sulfate; phenol; dibasic sodium phosphate heptahydrate; glycerol; metacresol; hydrochloric acid; zinc oxide - for the treatment of insulin dependent diabetic patients.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; protamine sulfate; metacresol; zinc oxide; glycerol; dibasic sodium phosphate heptahydrate; phenol - for the treatment of insulin dependent diabetic patients.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: metacresol; glycerol; water for injections; hydrochloric acid; sodium hydroxide - indications as at 05 feb 2002 : humulin is indicated for the treatment of insulin - dependant diabetic patients.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: zinc oxide; water for injections; phenol; sodium hydroxide; glycerol; metacresol; protamine sulfate; hydrochloric acid; dibasic sodium phosphate heptahydrate - for the treatment of insulin dependent diabetic patients.